Effects of meal size and composition on incretin, α-cell, and β-cell responses
Received 26 December 2008; accepted 28 July 2009. published online 21 October 2009.
Abstract
The incretins glucagon-like peptide–1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate postprandial insulin release from the β-cells. We investigated the effects of 3 standardized meals with different caloric and nutritional content in terms of postprandial glucose, insulin, glucagon, and incretin responses. In a randomized crossover study, 18 subjects with type 2 diabetes mellitus and 6 healthy volunteers underwent three 4-hour meal tolerance tests (small carbohydrate [CH]-rich meal, large CH-rich meal, and fat-rich meal). Non–model-based and model-based estimates of β-cell function and incremental areas under the curve of glucose, insulin, C-peptide, glucagon, GLP-1, and GIP were calculated. Mixed models and Friedman tests were used to test for differences in meal responses. The large CH-rich meal and fat-rich meal resulted in a slightly larger insulin response as compared with the small CH-rich meal and led to a slightly shorter period of hyperglycemia, but only in healthy subjects. Model-based insulin secretion estimates did not show pronounced differences between meals. Both in healthy individuals and in those with diabetes, more CH resulted in higher GLP-1 release. In contrast with the other meals, GIP release was still rising 2 hours after the fat-rich meal. The initial glucagon response was stimulated by the large CH-rich meal, whereas the fat-rich meal induced a late glucagon response. Fat preferentially stimulates GIP secretion, whereas CH stimulates GLP-1 secretion. Differences in meal size and composition led to differences in insulin and incretin responses but not to differences in postprandial glucose levels of the well-controlled patients with diabetes.
aEMGO Institute, VU University Medical Center, 1081 BT Amsterdam, The Netherlands
bDepartment of Epidemiology, Merck & Co., Inc., Clinical and Quantitative Sciences, North Wales, PA (USA)
cClinical and Quantitative Sciences, Merck & Co., Clinical Research, Inc., Rahway, NJ, USA
dInstitute of Biomedical Engineering, National Research Council, Padua, Italy
eDepartment of Medical Physiology, The Panum Institute, University of Copenhagen, Copenhagen
fDepartment of General Practice, VU University Medical Center, Amsterdam, The Netherlands